Cost-effectiveness of statin therapy for primary prevention of cardiovascular disease based on different LDL-C targets: a modelling study

30 August 2025 (08:15 - 09:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Miss Qiuping Liu

Beijing (China)

4 More presentations in this session

Presentation thumbnail

Rethinking prevention: why mental health should be at the heart of cardiovascular screening programs

Doctor J. Flores Soler (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

Bone mineral density and cardiovascular diseases: a two-sample mendelian randomisation study

Doctor D. Condurache (London, GB)

Abstract Slides Video

Presentation thumbnail

Costs of the initial 24-hour emergency room management of heart failure in a tertiary government hospital in the Philippines

Mr J. Joson (Manila, PH)

Abstract Slides Video

Presentation thumbnail

Mortality and hospitalisation costs due to acute myocardial infarction associated with systemic arterial hypertension in brazil from 2010 to 2019

Mr M. Dutra (Manaus, BR)

Abstract Slides Video

Access the full session

Session thumbnail

Perspectives in public health and cardiovascular diseases (3)

The Event

Event poster

ESC Congress 2025

30 August 2025 08:15 CET

You may be interested in

Congress Presentation

Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation

Congress Session

Disparities: insights into socioeconomic factors and cardiovascular health

Congress Session

The LDL-c challenge in patients with high cardiovascular risk: integrating innovative therapies in clinical management

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources